1. Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA.
2. EXSCALATE, Dompé farmaceutici S.p.A, Napoli, Italy.
3. Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
4. Department of Pediatrics, Johns Hopkins University School of Medicine, 1550 Orleans Street, CRB-II Room 109, Baltimore, MD 21287, USA.
5. Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
6. Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.
7. Department of Life, Health and Environmental Sciences, University of L’Aquila, L’Aquila, Italy.
8. Sbarro Institute for Cancer Research and Molecular Medicine, Department of Biology, Temple University, Philadelphia, PA 19122, USA.
9. Atreius S.a.s., L’Aquila, Italy.
10. Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
11. VIMM- Veneto Institute of Molecular Medicine, Fondazione per la Ricerca Biomedica Avanzata, Padova, Italy.
12. Department for Innovation in Biological, Agro-Food and Forest Systems, DIBAF, University of Tuscia, Viterbo, Italy.
13. Division of Preclinical Innovation, National Center for Advancing Translational Sciences, Rockville, MD 20850, USA.
14. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
15. Neuronal Networks Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA.
16. Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, L’Hospitalet de Llobregat, Catalonia, Spain.
17. Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
18. Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
19. Dompé farmaceutici S.p.A, L’Aquila, Italy.
20. Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.